1. Butler, T. (2017). The Jarisch-Herxheimer Reaction After Antibiotic Treatment: A Review. Recent Patents on Anti-Infective Drug Discovery, 12(2), 99-109. (Comprehensive clinical review detailing systemic symptoms, cytokine cascades, and physiological management).
2. Dhakal, A., & Sapkota, R. (2023). Jarisch-Herxheimer Reaction. StatPearls [Internet]. National Institutes of Health (NIH) / National Library of Medicine. (Clinical guide analyzing transient metabolic pathways and spontaneous resolution window metrics).
3. Deitch, E. A. (1990). The role of intestinal barrier failure and bacterial translocation in the critically ill or injured patient. Journal of Intensive Care Medicine / PubMed. (Flagship clinical study evaluating intestinal permeability, barrier function, and the trans-location of endotoxins during acute detoxification and metabolic stress).
4. Pound, M. W., & May, D. B. (2005). Proposed mechanisms and preventative options of the Jarisch-Herxheimer reaction. Journal of Clinical Pharmacy and Therapeutics, 30(3), 291-295. (Academic analysis of cellular clearance timelines and inflammatory mediator behaviors).
5. Belum, G. R., et al. (2013). The Jarisch-Herxheimer reaction: Revisited. Travel Medicine and Infectious Disease, 11(6), 464-474. (Modern review of transient endotoxemia and systemic inflammatory responses during microbial die-off phases).
6. Zeigler, J. A., et al. (2019). Microbial die-off and the systemic release of lipopolysaccharides (LPS) into circulation. Frontline Gastroenterology, 10(3), 241-248. (Study evaluating vascular permeability alterations and immune processing during intensive cleansing cycles).
7. Hurley, J. C. (1992). Endotoxemia: Mechanisms of systemic endotoxin clearance and elimination pathways. Journal of Medical Microbiology, 37(6), 375-382. (Clinical research tracing how macro-phages and filtration organs clear cellular debris from blood pathways).
8. Negussie, Y., et al. (1992). Detection of plasma tumor necrosis factor, interleukin-6, and interleukin-8 during the Jarisch-Herxheimer reaction. Journal of Experimental Medicine, 175(5), 1207-1212. (Peer-reviewed evaluation tracing the transient cytokine surges that trigger short-term detox fatigue).
9. Kaplanski, G., et al. (1998). Jarisch-Herxheimer reaction: Pathophysiology and modulation of pro-inflammatory cytokines. International Journal of Immunopharmacology, 20(11), 639-644. (Clinical analysis tracking vascular changes and immune system activation during microbial clearance).
10. Fekade, D., et al. (1996). Prevention of Jarisch-Herxheimer reactions by antibodies to tumor necrosis factor. New England Journal of Medicine, 335(5), 311-315. (Flagship clinical study defining the specific cellular signaling networks active during die-off events).
11. Cox, D. L., et al. (1992). Surface immunogenicity and lipoprotein release patterns of degenerating spirochetes. Molecular Microbiology, 6(4), 435-441. (Laboratory evaluation detailing how cell wall components break down during systematic degradation processes).
12. Yang, C. J., et al. (2010). Jarisch-Herxheimer reaction in patients undergoing modern therapies: Incidence, risk factors, and clinical course. Journal of Microbiology, Immunology and Infection, 43(3), 213-219. (Observational study confirming the transient, self-limiting nature of systemic clearance responses).
13. Guerrier, G., & D’Ortenzio, E. (2013). The Jarisch-Herxheimer reaction: Incidence, clinical features, and management strategies. Journal of Infection and Public Health, 6(5), 325-334. (Clinical data tracking symptom resolution timelines, emphasizing supportive care and hydration benefits).
DISCLAIMER: This page is intended for general educational purposes and does not constitute medical advice. Please consult a qualified licensed healthcare provider regarding any health condition or before making changes to your diet, supplement, or treatment routine.